The purpose of this study is to evaluate the safety, tolerability and efficacy of 3 doses of GRT6005 taken once daily for 4 weeks in outpatients with moderate-to-severe painful osteoarthritis of the knee.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01357837?cond=%22Arthritis%22&lup_s=07/14/2011&lup_d=30
